about
Temozolomide for high grade gliomaTreating malignant glioma in Chinese patients: update on temozolomideFingolimod for the treatment of neurological diseases-state of play and future perspectivesExpression of TYMS in lymph node metastasis from low-grade glioma.Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical articleUncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?Mesenchymal migration as a therapeutic target in glioblastoma.Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines.The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?Expression and mutation analysis of Cyclin A and Ki-67 in glioma and their correlation with tumor progression.Human glioma cells induce hyperexcitability in cortical networks.Multiple resections for patients with glioblastoma: prolonging survival.Do neurooncological patients and their significant others agree on quality of life ratings?Review on quality of life issues in patients with primary brain tumorsImpact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a reviewNimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.Tumor Recurrence in a Glioblastoma Patient after Discontinuation of Prolonged Temozolomide Treatment.Clinical implications of Girdin protein expression in glioma.Survival after radiation therapy for high-grade glioma
P2860
Q24197645-51AD65B0-03B7-4CF3-A476-3CA674CC34FAQ26863755-DBA66917-35AF-4103-A6FB-0CFC5C377A3EQ27026175-5DC1EF8B-B399-4D8B-A096-407D148FD1D1Q30397716-47A8E237-741A-4B17-AFB1-C662B589E403Q33608509-F9355F2B-1516-4582-9125-FD8D71A5F802Q33828102-11459A5B-6CEB-4566-96D7-6A158D4F13DDQ34002994-83684539-8927-4CDD-90C9-1DBDBC753FB4Q34042498-C609DCF8-0999-4751-937D-825F65627E39Q35038271-2F6AF0A8-6214-4241-BC81-15BA17128137Q35944627-95ABC8E8-A09E-4F31-B7A0-5C3ADE2681D3Q36162265-43F44FB3-BAD5-4DD8-8906-8AB1DDE19A8DQ36979060-8032E278-039E-48B3-86EC-E5E992A9DA0DQ37405864-5CF9B06E-F7E0-4F0B-BD50-FCDAE90F17CEQ37761238-C9267096-6A60-44F8-8F16-68632A85DCB9Q37862136-72C5D671-0B66-4D0E-AFEE-B8CDC474DEFBQ38127413-EE9DEB27-B898-4DA3-89C6-6E3C83A82C88Q39279856-DF7D3601-2954-4B6F-BDD9-155260765B6CQ47140635-87C06D02-7453-4A46-9B08-49CD8A708BD2Q54518510-CC829EA7-1F1F-486B-9E3E-8453E12AA571Q58544790-9A7120FC-1CBE-4EAA-BCE3-3F22EAB5AD58
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Temozolomide for High Grade Glioma
@ast
Temozolomide for High Grade Glioma
@en
Temozolomide for High Grade Glioma
@en-gb
Temozolomide for High Grade Glioma
@nl
type
label
Temozolomide for High Grade Glioma
@ast
Temozolomide for High Grade Glioma
@en
Temozolomide for High Grade Glioma
@en-gb
Temozolomide for High Grade Glioma
@nl
prefLabel
Temozolomide for High Grade Glioma
@ast
Temozolomide for High Grade Glioma
@en
Temozolomide for High Grade Glioma
@en-gb
Temozolomide for High Grade Glioma
@nl
P2093
P2860
P1476
Temozolomide for High Grade Glioma
@en
P2093
Gabriel Rogers
Margaret Somerville
Michael G Hart
Robert Grant
Ruth Garside
P2860
P356
10.1002/14651858.CD007415
P577
2008-10-08T00:00:00Z